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ABSTRACT
Background: Although acetaminophen has been used
widely and is well tolerated in children, its efficacy and safety
have not been clarified when combined with an opioid in intra-
venous parent-/nurse-controlled postoperative analgesia.
Methods: Sixty-three children (aged 6–24months) who had
undergone elective ureteroneocystostomies were enrolled in
this prospective, randomized, double-blinded study. After
the surgery, an analgesic pump was programmed to deliver
fentanyl at a basal infusion rate of 0.25 g  kg1  h1 and
0.25 g/kg bolus after a loading dose of 0.5 g/kg. In the
fentanyl–acetaminophen group, acetaminophen was coad-
ministered as a solutionmixture at a basal infusion rate of 1.5
mg  kg1  h1 and 1.5 mg/kg bolus after a loading dose of
15mg/kg, whereas saline was administered to the fentanyl group.
Results: Postoperative pain scores were similar between the
two groups. The total dose (micrograms per kilogram per
day, mean SD) of fentanyl at postoperative days 1 (8.3
3.7 vs. 18.1 4.6, P 0.021) and 2 (7.0 2.4 vs. 16.6, P
0.042) was significantly less in the fentanyl–acetaminophen
group compared with that in the fentanyl group. The inci-
dences of vomiting (16.1 vs. 56.3%, P 0.011) and sedation
(9.7 vs. 46.9%, P  0.019) were significantly lower in the
fentanyl–acetaminophen group than those in the fentanyl
group.
Conclusions: Acetaminophen has significant fentanyl-spar-
ing effects and reduces side effects when combined with fen-
tanyl in intravenous parent-/nurse-controlled analgesia for
postoperative pediatric pain management.
PAIN after surgical procedures in children has receiveddeserved attention, especially in children undergoing
ureteral reimplantation who have suffered from moderate to
severe pain due to postoperative bladder spasms. Although
the precise mechanism of postoperative bladder spasms is not
known, there is evidence that suggests that prostaglandins
may play an important role.1,2
A ready-to-use injectable acetaminophen (Perfalgan 10
mg/ml; Bristol-Myers-Squibb GmbH, Munich, Germany)
works by inhibiting the cyclooxygenase enzyme in the central
nervous system while sparing peripheral prostaglandin pro-
duction. Intravenous acetaminophen has been shown to pro-
vide effective postoperative analgesia and is well tolerated in
children,3,4 but currently there has been no information re-
garding its continuous administration with opioids in pediatric
pain management. The effective use of acetaminophen could
contribute to keeping the postoperative opioid requirement and
the potential for opioid-related adverse effects5 to a minimum,
particularly in infants and small children.
We designed a prospective, randomized, double-blinded
study to evaluate the effects of acetaminophen combined
with fentanyl as an intravenous parent-/nurse-controlled an-
algesia (PNCA)6 on postoperative analgesic efficacy and to
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What We Already Know about This Topic
❖ Acetaminophen is a useful adjunct for postoperative analge-
sia, but its application by parent-/nurse-controlled intrave-
nous analgesia with fentanyl in infants has not been examined
What This Article Tells Us That Is New
❖ In 63 infants (6–24 months old), addition of acetaminophen to
intravenous fentanyl parent-/nurse-controlled analgesia after
ureteroneocystostomy reduced fentanyl dose, vomiting, and
sedation by more than 50%
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examine the adverse effects it has in infants and small chil-
dren undergoing elective ureteroneocystostomy.
Materials and Methods
This study was approved by the Institutional Review Board
(Yonsei University Health System Clinical Trial Center in
Seoul, Republic of Korea), and informed consent was ob-
tained from the parents of the patients. On the day of the
preanesthetic visit, parents were taught the principles of
PNCA and were explained their role in the study. Every
participating parent should be at the child’s bedside contin-
uously for PNCA during the study period because the parent
should activate the PNCA device (AutoMed3200; AceMedical,
Seoul, Republic of Korea) when necessary. Written instruc-
tions for the parents as the “primary pain manager” were
provided. The instructions included the process of PNCA,
pediatric pain assessment, and how to monitor the adverse
effects of PNCA and then notify the anesthesiologist in the
ward as needed.
We enrolled 63 full-term infants and small children
(physical status I or II according to the American Society of
Anesthesiology) who were between 6 and 24 months of age
and scheduled for elective ureteroneocystostomies. Patients
were excluded if they had a known allergy to acetaminophen,
kidney or liver dysfunction, or received other analgesics or
sedatives before the surgery.
Before the induction of anesthesia, patients were randomly
separated into twogroups using a computer-generated random-
ization table. Premedication was not administered. Anesthe-
sia was induced with 5 mg/kg thiopental sodium, and 0.6
mg/kg rocuronium was given for tracheal intubation while
under standard monitoring. Then, mechanically controlled
ventilation was used to maintain end-tidal carbon dioxide at
35  5 mmHg during the surgery. Anesthesia was main-
tained with 1.0–4.0 vol% end-tidal sevoflurane in an air–
oxygen mixture (fraction of inspired oxygen  0.5). The
concentration of end-tidal sevoflurane was adjusted accord-
ing to the clinical parameters (blood pressure or heart rate
within 20% of the baseline). All patients received 1 g/kg
intravenous fentanyl before the surgical incisions. The pe-
ripheral oxygen saturation, heart rate, and noninvasive blood
pressure were monitored and recorded throughout the sur-
gery. The same urologist performed all surgical procedures to
maintain a uniform application of surgical stimulus.
At the peritoneal closure, the children in the fentanyl–
acetaminophen (F–P) group received an intravenous bolus
dose of 0.5 g/kg fentanyl and 15 mg/kg acetaminophen,
whereas the patients in the fentanyl group received 0.5g/kg
fentanyl and saline. One nurse prepared all of the initial
boluses and PNCA drugs, and this nurse was not involved in
the surgical procedure or postoperative care. The anesthesi-
ologist who administered the injections was unaware of their
content. After emerging from anesthesia, a PNCA pump was
attached to an intravenous catheter by an anesthesiologist
blinded to the drug mixture. The intravenous infusion tub-
ing contained a one-way, back-check valve to prevent back-
flow and inadvertent dosing of the drug by gravity. The
duration of postoperative painmanagement using the PNCA
pump was limited to 72 h.
In the F–P group, the syringe contained 1.5 g/ml fent-
anyl and 9 mg/ml acetaminophen. In the fentanyl group, the
syringe contained only 1.5 g/ml fentanyl. In both groups,
the basal infusion was set at 0.166 ml  kg1  h1. Patients
in the F–P group thus received a postoperative basal infusion
of 0.25 g  kg1  h1 fentanyl and 1.5 mg  kg1  h  1
acetaminophen, whereas patients in the fentanyl group re-
ceived only 0.25 g  kg1  h1 fentanyl. For breakthrough
pain despite the basal infusion, patients received 0.166ml/kg
bolus doses (0.25 g/kg fentanyl and 1.5 mg/kg acetamino-
phen), with lock-out intervals of 30 min and a 6-h limit of
four bolus doses (giving a 6-h maximum total dose of fenta-
nyl and acetaminophen of 2.5 g/kg and 15 mg/kg, respec-
tively). If the patient seemed to be consistently uncomfort-
able with these initial settings despite the repeated bolus
doses for 1 h, the fentanyl dose of themixture was doubled by
the anesthesiologist blinded to the drug mixture. Similarly, if
a child seemed to be overly sedated or desaturated, the dose
was reduced by half.
Both the nurse, who was blinded to the group allocation
and stationed in the recovery room, and the educated parent
in the ward were allowed to administer bolus doses to the
child when they seemed to be in pain (4 on the Children’s
Hospital of Eastern Ontario Pain Scale).7 Throughout the
PNCA use, the patient’s vital signs and adverse effects were
monitored by the nurse or parent. If the child had any ad-
verse effects, the infusion was temporarily stopped, and a
blinded anesthesiologist was immediately notified for appro-
priate management.
Postoperative sedation was evaluated using the eight-
point modified Ramsay Sedation Scale,8 and oversedation
was defined as more than 4. Postoperative desaturation was
defined as a decreasing peripheral oxygen saturation of less
than 90%. Continuous pulse oximetry was performed for all
children during the first 24 h of PNCA use and whenever the
bolus doses were increased. Supplemental oxygen was pro-
vided for oxygen saturations less than 95%. Supplemental
oxygen and naloxone were prepared on an as-needed basis for
all patients in the case of desaturation. A total of 0.1 mg/kg
ondansetron was administered if patients vomited even once.
One milligram per kilogram pheniramine maleate was given
when patients showed pruritus.
The postoperative total doses of fentanyl (as a primary
outcome), pain scores measured by the parent, and adverse
effects (as a secondary outcome), including vomiting, seda-
tion, pruritus, desaturation, and poor oral feeding at 1, 6, 12,
24, 36, 48, 60, and 72 h after surgery were recorded. A liver
function test (serum glutamic-oxaloacetic transaminase and
glutamic pyruvictransferase) and urine analysis (pH, specific
gravity, glucose, protein, and bilirubin content) were per-
formed on the first and third postoperative days. After com-
pletion of the study, a questionnaire was distributed to assess
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the satisfaction level of the parents on a four-point scale
(excellent 1, good 2, fair 3, and poor 4).
The sample size was taken from data previously published
by Choi et al.,9 who found that the total dose of fentanyl
during the first postoperative day in similarly aged children at
a basal infusion rate of 0.5 g  kg1  h1 was 13.5  0.5.
Thirty patients in each group allowed for an alpha of 0.05
and a power of 0.9 for a 30% difference in the reference
value. All data were expressed as the mean  SD or the
number (%) of patients. Statistical analyses were performed us-
ing SPSS 12.0 (SPSS Inc., Chicago, IL). The differences be-
tween the two groups were analyzed using the two-tailed Stu-
dent t test, Mann-Whitney rank sum test, chi-square test, and
Fisher exact test when appropriate. A normality test was per-
formed using the Kolmogorov-Smirov and Shapiro-Wilk tests.
A repeated-measured ANOVA with Bonferroni correction was
performed to test for intergroup difference in terms of the total
fentanyl doses and pain scores measured at the designated time
points from 1 to 72 h. P 0.05 was considered significant.
Results
A total of 63 patients were enrolled, and no patient was
excluded or dropped out, leaving 32 patients in the fentanyl
group and 31 patients in the F–P group. The two groups
were comparable in terms of age, weight, height, duration of
surgery, and intraoperative fluid administration (table 1).
PNCA was successfully administered to all patients in the
recovery room and the wards. All parents stayed with their
children at their bedside, and they did not reject administer-
ing analgesics to their children during the study. No techni-
cal problems related to the use of the PNCA pumps were
found during the study.
The total dose of fentanyl at postoperative days 1 and 2
was significantly lesser by half in the F–P group compared
with that in the fentanyl group, as summarized in table 2.
The cumulative dose of fentanyl for the 3 days after surgery
was also significantly lower in the F–P group than that in the
fentanyl group (fig. 1). In the fentanyl group, 14 children
(43.8%) were given “double fentanyl” 1–2 times each on
postoperative day 1 and another four (12.5%) on postopera-
tiveday2because of inadequate analgesia.Nopatient in theF–P
groupneeded a higher fentanyl concentration.The dosing strat-
egy was never decreased because neither of the two groups
showed oversedation or desaturation during the study.
Postoperative pain scores between the two groups re-
corded at 1, 6, 12, 24, 36, 48, 60, and 72 h after the surgery
were not significantly different (fig. 2).
Table 3 compares the incidences of side effects of the
groups 3 days after the surgery. The fentanyl group had a
significantly greater number of patients who vomited and
had Ramsay scores higher than 4 compared with the F–P
group. However, the patients who vomited postoperatively
were well controlled by a single dose of ondansetron. Pruritus
was spontaneously resolved in one child in the F–P group,
and it was treated with pheniramine in three children in the
fentanyl group and one child in the F–P group. There was no
postoperative desaturation in either group.
The liver function test and urine analysis at postoperative
days 1 and 3 did not show significant intergroup differences.
The majority of patients (84.4% of the fentanyl group and
Table 1. Demographic Data and Intraoperative Characteristics
Fentanyl Group (n  32) F–P Group (n  31)
Age, mo 17.8  10.4 (6–22) 16.9  8.3 (6–24)
Weight, kg 11.4  2.5 (7–20) 10.6  2.4 (8–17)
Height, cm 80.0  10.6 (69–98) 80.9  11.1 (63–99)
Duration of surgery, min 94.5  18.4 (65–120) 97.7  23.0 (70–135)
Fluid administered, ml 181  92 (90–255) 184  68 (100–240)
Data are given as mean  SD (ranges). There was no difference in variables between the groups.
F–P group  fentanyl–acetaminophen group.
Table 2. Total Doses of Fentanyl and Acetaminophen during the Postoperative Period
Fentanyl Group (n  32) F–P Group (n  31) P Value
Day 1
Fentanyl, g  kg1  d1 18.1  4.6 8.3  3.7 0.021
Acetaminophen, mg  kg1  d1 — 49.8  3.8
Day 2
Fentanyl, g  kg1  d1 16.6  5.5 7.0  2.4 0.042
Acetaminophen, mg  kg1  d1 — 42.2  3.6
Day 3
Fentanyl, g  kg1  d1 12.5  5.8 6.4  3.0 0.357
Acetaminophen, mg  kg1  d1 — 39.5  4.2
Data are given as mean  SD. Fentanyl dose at postoperative days 1, 2, and 3 was significantly lower in the fentanyl–acetaminophen
group (F–P group) compared with the fentanyl group.
PAIN MEDICINE
674 Anesthesiology, V 113 • No 3 • September 2010 Hong et al.
100% of the F–P group) were satisfied (excellent or good)
with the PNCAmodality (table 4). Patients in the F–P group
were more satisfied with the PNCA than those in the fenta-
nyl group according to the chi-square test (P  0.020).
Discussion
Our data confirm for the first time that PNCA, which was
administered as a mixture of fentanyl and acetaminophen,
was efficacious for postoperative pain control after pediatric
ureteroneocystostomy. The results also indicate that contin-
uous intravenous acetaminophen has significant fentanyl-
sparing effects and is associated with fewer side effects com-
pared with fentanyl alone.
In this study, the average fentanyl dose used for the fent-
anyl group was approximately 0.75g  kg1  h1, which is
close to the median dose (0.86 g  kg1  h1 with a range
of 0.6–1.17) as reported by Monitto et al.6 in their fentanyl
group using PNCA. The analgesic effect of intravenous acet-
aminophen is directly related to its plasma concentration.
For postoperative pain, plasma acetaminophen levels of
10–20 mg/l are considered therapeutic for analgesia in chil-
dren with peak therapeutic effects after about 1 h of postpeak
plasma levels for all routes of administration.10,11 Although
we did not measure acetaminophen concentrations, we can
expect that the plasma concentrations of acetaminophen in
our patients were lower than those in previous reports4,12
because we administered smaller doses of acetaminophen
than the recommended total daily dose in the United King-
dom and Australia (60 mg  kg1  day1).13,14 It is interest-
ing that the analgesic effects might be attributable in part to
continuous administration of acetaminophen because the
bolus doses of acetaminophen were infrequently adminis-
tered. Therefore, further pharmacologic studies regarding
the concentration of acetaminophen when using continuous
infusion are needed.
Our results suggest a possible synergic interaction be-
tween fentanyl and acetaminophen, although this study did
not address this issue. There are some previous animal studies
about the interactions between these two drugs. Gaitan
et al.15 demonstrated that a subanalgesic dose of nitroparac-
etamol strongly potentiated fentanyl antinociception in rats.
The development of acute tolerance of fentanyl is also pre-
vented by the combined administration of these drugs,15 but
Fig. 1. The cumulative fentanyl dose (g/kg) for 3 days after
surgery. F group  fentanyl group; F–P group  fentanyl–
acetaminophen group. The cumulative dose of fentanyl at 1,
6, 12, 24, 36, 48, 60, and 72 h after surgery was significantly
lower in the F–P group than in the fentanyl group. * P  0.05
compared with the F–P group.
Fig. 2. Postoperative pain scores based on the Children’s
Hospital of Eastern Ontario Pain Scale (CHEOPS, 0–10). F
group  fentanyl group; F–P group  fentanyl–acetamino-
phen group. Pain scores recorded at 1, 6, 12, 24, 36, 48, 60,
and 72 h after surgery did not show statistically significant
differences between the two groups.





(n  31) P Value
Vomiting 18 (56.3) 5 (16.1) 0.011
Sedation 15 (46.9) 3 (9.74) 0.019
Pruritus 3 (9.4) 2 (6.5) 0.515
Poor oral feeding 4 (12.5) 0 (0) 0.060
Desaturation 0 (—) 0 (—) —
Data are given as the number (%) of patients. Sedation: modified
Ramsay Sedation Scale 4. Desaturation: pulse oximeter values
90%. There was no respiratory depression in either group.
F–P group  fentanyl–acetaminophen group.





Excellent 10 (31.3) 18 (58.1)
Good 17 (53.1) 13 (41.9)
Fair 5 (15.6) 0 (0)
Poor 0 (0) 0 (0)
Data are given as the number (%) of patients. Patients in the
fentanyl–acetaminophen group (F–P group) were more satisfied
with parent-/nurse-controlled analgesia (PNCA) than those in the
fentanyl group according to the chi-square test (P  0.020). .
Fentanyl-sparing Effect of Acetaminophen in Children
Hong et al. Anesthesiology, V 113 • No 3 • September 2010 675
the mechanism remains unclear. Further experimental stud-
ies are required to elucidate the underlying mechanisms, but
it seems that they do not involve direct opioid receptor acti-
vation. Otherwise, acetaminophen could inhibit fentanyl
metabolism. In an in vitro study by Feierman,16 acetamino-
phen inhibited the oxidation of fentanyl to norfentanyl in a
concentration-dependent manner. According to the kinetic
analysis,16 10–20 mg/l acetaminophen inhibited the fenta-
nyl metabolism in a normocompetitive fashion. Further clin-
ical investigation in humans is needed to determine whether
acetaminophen affects the bioavailability of fentanyl.
PNCA is considered a safe and efficacious modality for
postoperative pain control in infants and small children.17,18
Although PNCA has become common practice in our insti-
tution and no patient showed PNCA-related respiratory
compromises in our study, there are still some concerns re-
garding the risk of overdosage and the potential of respiratory
compromise. It is unclear whether PNCA causes fewer or
more respiratory complications than routine p.r.n. dosing of
opioids in children because few data are available for com-
parison.6,9,19 Particular attention, of course, must be paid to
each child’s coexisting medical problems and the use of ad-
ditional sedatives, both of which may decrease the safety
margin of the technique. In addition, we advocate that
PNCA could be used only in settings in which adequate
resources are available to minimize the risk of serious com-
plications and to intervene rapidly and effectively if compli-
cations do occur. Our teaching hospital includes a Hospital
Pain Service Center with 24-h, extensive, and careful moni-
toring with nursing protocols and parent education.
Although the incidence of respiratory complications asso-
ciated with patient-controlled analgesia using opioids has
been found to be small, previous studies have shown that
many patients who received intravenous patient-controlled
analgesia experienced opioid-related side effects. For exam-
ple, nausea and vomiting have been reported in 30–50% of
children receiving patient-controlled analgesia,20,21 and pru-
ritus has been reported in up to 20% of patients.21 We ob-
served similar incidences of these side effects in our patients
receiving PNCA using only fentanyl.
However, PNCA with the F–P mixture required signifi-
cantly less fentanyl than those receiving fentanyl alone. Con-
sequently, we found that acetaminophen combinedwith fen-
tanyl in a PNCA regimen significantly decreased the
incidence of fentanyl-related side effects as we had expected.
Several studies have revealed significant morphine-sparing
effects of acetaminophen in adults and children
(24–36%),22–24 but the benefits of a drug combination in
terms of side effects was documented in only one study.25
Remy et al.25 suggested in their meta-analysis of randomized
controlled trials that acetaminophen using patient-con-
trolled analgesia had a significant morphine-sparing effect
(20%) but did not change the incidence of morphine-related
adverse effects, including nausea, vomiting, and sedation,
during the postoperative period. However, it is difficult to
understand the failure of acetaminophen to decrease these
side effects despite the decrease in morphine requirement.
These could be explained by the limitation of their review. In
their study, not all morphine side effects were reported. Fur-
thermore, the study was performed on too few numbers of
patients.
Despite the clinical effects of this study, special caution is
required in general application. Recently, low to moderate
grade reflux is less often treated with ureteral implantation
but rather with endoscopic collagen injections.26 In addi-
tion, many anesthesiologists might prefer regional tech-
niques for the control of lower abdominal pain after reim-
plantation. However, the benefit-to-risk ratio of regional
techniques should be reconsidered in some children.27
Therefore, PNCAwith opioids and acetaminophen could be
offered as an important alternative to regional blocks, such as
for children with neurologic disorders or spinal anomalies,
and older and/or obese children in whom caudal blocks are
often difficult to perform successfully. When this technique
is used in critically ill patients, more sensitive monitors will
be needed because of the risks of apnea and desaturation.6
In conclusion, we demonstrated that acetaminophen has
a significant fentanyl-sparing effect and could reduce the side
effects of opioids when combined with fentanyl-based intra-
venous PNCA for postoperative analgesia in children who
have undergone ureteroneocystostomies.
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